This week, the FDA and CDC authorized new booster shots from both Pfizer and Moderna that are tweaked to specifically target Omicron BA.4 and BA.5. Here are some data considerations for the new boosters.
Read MoreSources and updates for the week of July 31 include slow vaccine uptake for young kids, next-generation vaccines, COVID-19’s origins, and more.
Read More
This week, the FDA’s vaccine advisory committee met to discuss fall booster shots, in anticipation of another COVID-19 surge next winter. The discussion demonstrated the U.S.’s continued failure to provide the data that are really needed to make these decisions.
Read MoreSources and updates for the week of May 8 include booster shots, vaccine attitudes, wastewater data, and source diversity.
Read More
Last fall, I wrote that the U.S. did not have the data we needed to make informed decisions about booster shots. Several months later, we still don’t have the data we need, as questions about a potential BA.2 wave and other future variants abound. Discussions at a recent FDA advisory committee meeting made these data gaps clear.
Read MoreSources and updates for the week of March 13 include vaccine data annotations, free rapid tests, a combination of Delta and Omicron, and more.
Read More
What has the U.S. learned from the last two years, and what lessons can we take forward for future COVID-19 surges and other infectious disease outbreaks? The Biden administration has released a new pandemic preparedness plan that addresses these questions.
Read More
As more states and other institutions lift COVID-19 safety measures, the shift has sparked a conversation about who remains most vulnerable to COVID-19 during this period. These vulnerable groups include unvaccinated and unboosted seniors, immunocompromised people, and pregnant people.
Read More
Omicron updates for the week of February 13 include BA.2 estimates, vaccine effectiveness from a booster shot, COVID-19 in deer, and more.
Read More
Omicron updates this week include BA.2’s transmissibility, the importance of vaccination to protect against severe symptoms, and the U.S.’s high death toll.
Read More